Introduction: Osteoarthritis (OA) is now recognized as a chronic inflammatory disease rather than a passive degenerative condition. Macrophages play a central role in OA pathogenesis, with the M1 pro-inflammatory phenotype driving cartilage degradation and chondrocyte apoptosis, while the M2 pro-regenerative phenotype promotes tissue repair. The pathological imbalance of the M1/M2 ratio in OA has emerged as a key therapeutic target. This review summarizes scaffold-based strategies for M2 macrophage polarization in OA and discusses the challenges of clinical translation
Materials and Methods: A systematic literature search was conducted using PubMed, Web of Science, and Scopus databases up to January 2026. Studies were included if they addressed scaffold-based immunomodulation, macrophage polarization, and cartilage regeneration in the context of osteoarthritis.
Results: Preclinical evidence consistently demonstrates that macrophage-polarizing scaffolds, through the integration of biomaterial selection, mechanical cues, surface topography, and controlled delivery of immunomodulatory agents, can effectively shift the M1/M2 balance toward a pro-regenerative state. These scaffolds promote chondrogenesis, reduce cartilage degradation, and improve joint functionality in animal models. However, several challenges remain, including patient-specific inflammatory profiles, spatiotemporal control of immune modulation, scalable manufacturing, and appropriate sterilization methods that preserve immunomodulatory properties.
Conclusion: Macrophage-polarizing scaffolds represent an active immunomodulatory approach for cartilage regeneration, shifting from passive supports to engaging the immune system, with future directions focused on personalized and multifunctional designs targeting both cartilage and bone.
Type of Study:
Research |
Subject:
Genetics/ Biotechnology Received: 2026/06/30 | Accepted: 2025/09/1